← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lund University
Lund
$3,419,080
Total funding
3
Grants
Funding over time
peak $329.6K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$3,419,080 · 3
By mechanism
U10$1,706,741 · 1
U01$1,455,839 · 1
R21$256,500 · 1
Investigators at Lund University
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
EARLY MANIFEST GLAUCOMA TRIAL$393,750
U10 · FY2002 · EY
EARLY MANIFEST GLAUCOMA TRIAL$350,000
U10 · FY2000 · EY
EARLY MANIFEST GLAUCOMA TRIAL$332,400
U10 · FY2003 · EY
Novel OA-markers by integrating basic biology and clinic$329,585
U01 · FY2005 · AR
EARLY MANIFEST GLAUCOMA TRIAL$315,591
U10 · FY2004 · EY
EARLY MANIFEST GLAUCOMA TRIAL$315,000
U10 · FY2001 · EY
Novel OA-markers by integrating basic biology and clinic$312,681
U01 · FY2007 · AR
Novel OA-markers by integrating basic biology and clinic$309,476
U01 · FY2006 · AR
Novel OA-markers by integrating basic biology and clinic$265,035
U01 · FY2004 · AR
Novel OA-markers by integrating basic biology and clinic$239,062
U01 · FY2003 · AR
ADULT STEM CELL THERAPY IN PARKINSON'S DISEASE$128,250
R21 · FY2003 · NS
ADULT STEM CELL THERAPY IN PARKINSON'S DISEASE$128,250
R21 · FY2004 · NS